Condition

Congenital Dyserythropoietic Anemia (CDA) clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Congenital Dyserythropoietic Anemia (CDA) clinical trials that are recruiting, at sites in 3 countries (most in United States (1), Spain (1), China (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Congenital Dyserythropoietic Anemia (CDA) clinical trials

StudyPhaseWhereStatusRegistered
Zoledronic acid treatment for adults with congenital dyserythropoietic anemia Phase 1/2 Tianjin Recruiting Mar 13, 2026
Integrated diagnosis for sickle cell disease and other rare anemias — Barcelona and 3 other locations Recruiting Oct 3, 2025
Registry for patients with Congenital Dyserythropoietic Anemia — Cincinnati, Ohio Recruiting Nov 16, 2016

All recruiting trials (3)

Related topics

AnemiaSickle Cell Disease

Quick answers

How many Congenital Dyserythropoietic Anemia (CDA) clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (1 trial), Spain (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.